Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

“Taking these medications puts individuals at risk of everything from allergic reactions to uncontrolled blood sugar levels, ...

Oprah Winfrey gained a new perspective. The media mogul, throughout her career, has been candid about her journey with weight, and that remained true as she began using weight loss medications.

Novo Nordisk's stock (NVO) rose more than 8% in Friday trading on news that the company's latest weight-loss product delivered favorable results. The new drug, amycretin, similar to the company's ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

International Community Health Services (ICHS) has launched Together We Rise, a wellness podcast with useful information ...

Novo Nordisk (NYSE:NVO) shares are rallying 6.87% to $86.67 as of 10:27 AM ET Friday, after the company reported promising trial results for its new obesity drug ... to 22% weight loss over ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV special focuses on the drugs.

Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...

Oprah Winfrey is sharing new details on her weight loss ... weight-loss drug would be “the easy way out.” But she later realized "the fact that there’s a medically approved prescription ...

The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...

Such vulnerabilities reveal systemic weaknesses, especially when drugs like Wegovy should only be prescribed under close clinical supervision. A significant concern is the prescription of Wegovy ...